Disc Medicine (IRON) EBITDA

Annual EBITDA

-$91.03 M
-$43.64 M-92.09%

December 31, 2023


Summary


Performance

IRON EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRONprofitabilitymetrics:

Quarterly EBITDA

-$32.84 M
-$2.10 M-6.84%

September 30, 2024


Summary


Performance

IRON Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRONprofitabilitymetrics:

TTM EBITDA

-$124.71 M
-$13.91 M-12.56%

September 30, 2024


Summary


Performance

IRON TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIRONprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IRON EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-92.1%-73.5%-63.4%
3 y3 years-170.2%-73.5%-63.4%
5 y5 years-170.2%-73.5%-63.4%

IRON EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-194.6%at low-256.1%at low-998.8%at low
5 y5-year-194.6%at low-256.1%at low-1210.5%at low
alltimeall time-194.6%at low-256.1%at low-1210.5%at low

Disc Medicine EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$32.84 M(+6.8%)
-$124.71 M(+12.6%)
Jun 2024
-
-$30.74 M(-2.2%)
-$110.80 M(+13.8%)
Mar 2024
-
-$31.44 M(+5.9%)
-$97.36 M(+7.0%)
Dec 2023
-$91.03 M(+92.1%)
-$29.69 M(+56.8%)
-$91.03 M(+19.2%)
Sep 2023
-
-$18.93 M(+9.4%)
-$76.33 M(+12.5%)
Jun 2023
-
-$17.30 M(-31.1%)
-$67.85 M(+8.5%)
Mar 2023
-
-$25.10 M(+67.4%)
-$62.54 M(+32.0%)
Dec 2022
-$47.39 M
-$15.00 M(+43.4%)
-$47.39 M(+317.5%)
Sep 2022
-
-$10.46 M(-12.8%)
-$11.35 M(-41.1%)
Jun 2022
-
-$11.99 M(+20.6%)
-$19.28 M(-18.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$9.94 M(-147.3%)
-$23.55 M(-23.4%)
Dec 2021
-$30.90 M(-8.3%)
-
-
Dec 2021
-
$21.04 M(-214.4%)
-$30.75 M(-31.0%)
Sep 2021
-
-$18.39 M(+13.1%)
-$44.56 M(+30.9%)
Jun 2021
-
-$16.26 M(-5.1%)
-$34.05 M(+39.7%)
Mar 2021
-
-$17.14 M(-337.1%)
-$24.37 M(+45.5%)
Dec 2020
-$33.69 M
$7.23 M(-191.7%)
-$16.75 M(-30.1%)
Sep 2020
-
-$7.88 M(+19.6%)
-$23.98 M(+48.9%)
Jun 2020
-
-$6.59 M(-30.8%)
-$16.10 M(+69.2%)
Mar 2020
-
-$9.52 M
-$9.52 M

FAQ

  • What is Disc Medicine annual EBITDA?
  • What is the all time high annual EBITDA for Disc Medicine?
  • What is Disc Medicine annual EBITDA year-on-year change?
  • What is Disc Medicine quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Disc Medicine?
  • What is Disc Medicine quarterly EBITDA year-on-year change?
  • What is Disc Medicine TTM EBITDA?
  • What is the all time high TTM EBITDA for Disc Medicine?
  • What is Disc Medicine TTM EBITDA year-on-year change?

What is Disc Medicine annual EBITDA?

The current annual EBITDA of IRON is -$91.03 M

What is the all time high annual EBITDA for Disc Medicine?

Disc Medicine all-time high annual EBITDA is -$30.90 M

What is Disc Medicine annual EBITDA year-on-year change?

Over the past year, IRON annual EBITDA has changed by -$43.64 M (-92.09%)

What is Disc Medicine quarterly EBITDA?

The current quarterly EBITDA of IRON is -$32.84 M

What is the all time high quarterly EBITDA for Disc Medicine?

Disc Medicine all-time high quarterly EBITDA is $21.04 M

What is Disc Medicine quarterly EBITDA year-on-year change?

Over the past year, IRON quarterly EBITDA has changed by -$13.91 M (-73.48%)

What is Disc Medicine TTM EBITDA?

The current TTM EBITDA of IRON is -$124.71 M

What is the all time high TTM EBITDA for Disc Medicine?

Disc Medicine all-time high TTM EBITDA is -$9.52 M

What is Disc Medicine TTM EBITDA year-on-year change?

Over the past year, IRON TTM EBITDA has changed by -$48.38 M (-63.38%)